Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 441-100-8 | CAS number: 351197-46-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
oral, rat 300 mg/kg bw < LD50 < 2000 mg/kg bw
dermal, rat LD50 > 2000 mg/kg bw
Key value for chemical safety assessment
Additional information
Oral
In an acute oral toxicity GLP study according to OECD 423, three groups, each consisting of 3 female RccHan:WIST (SPF) rats, were treated by oral gavage with UAX-1179 at 300 (2 groups) and 2000 mg/kg body weight (Sieber, 2011). The test item was applied in a volume of 10 mL/kg bw. All animals treated with 300 mg/kg bw (Groups 1 and 3) survived the observation period. All animals treated with 2000 mg/kg bw (Group 2) died after treatment on test day 1. All animals of the highest dose group (2000 mg/kg bw) showed marked shivering, muscle twitching, markedly decreased activity, prostration and marked dyspnea prior to their death within 1 hour after treatment. Animals in Group 1 treated with 300 mg/kg body weight showed slightly to moderately ruffled fur on test Days 1-2. Otherwise, no clinical signs were observed during the course of the study. The body weight of the animals was within the range commonly recorded for this strain and age. No macroscopic findings were observed at necropsy. The oral LD50 value of UAX-1179 after single administration to female rats, observed over a period of 14 days is considered to be between 300 and 2000 mg/kg body weight.
In a second study, UAX-1179 was tested under GLP according to OECD-Guideline 423 for oral acute toxicity in HanBrl: WIST (SPF) rats (Damme, 2002). Two of three females treated with 2000 mg/kg body weight of the test item by gavage died within two hours after administration. All animals treated with 200 mg/kg bw survived the end of the study period. Slight to moderate convulsions, sedation and ventral recumbency were observed at the highest dose group. No macroscopic findings were observed at necropsy. The oral LD50 value of UAX-1179 is considered to be between 200 and 2000 mg/kg body weight in rat.
Inhalation
Taking into account UAX-1179 has a very slow vapour pressure of 0.0014 Pa the substance is not inhalable. The formation of aerosol can be excluded by uses (see 3.5). No acute inhalation toxicity is expected.
Dermal
After dermal application of 2000 mg/kg bw of the undiluted test item for 24 hours, no deaths occurred during the GLP-Guideline study (Arcelin, 2002). Slight erythema was observed in all male and female animals from test day 2 after removal of the dressing to test day 5, and persisted until test day 6 in two male animals and until test day 9 in one male and three female animals. The median lethal dose of UAX-1179 after single dermal administration to rats of both sexes, observed over a period of 14 days is greater than 2000 mg/kg body weight.
Justification for classification or non-classification
In accordance with EEC Directive 67/548 the test item UAX-1179 is to be classified as harmful, if swallowed (Xn, R22).
In accordance with the Globally Harmonised System (Regulation (EC) No 1272/2008), UAX-1179 is classified as acute tox cat 4 as harmful, if swallowed (H302).
DSD: Xn, R22, harmful, if swallowed
CLP: Acute tox. cat. 4, H302, harmful if swallowed, with the signal word: warning
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.